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   Abstract 
Magnetic resonance imaging (MRI) is one of the non-invasive imaging modalities used in 
longitudinal cell tracking. Previous studies suggest that MagA, a putative iron transport 
protein from magnetotactic bacteria, is a useful gene-based magnetic resonance contrast 
agent. Hemagglutinin (HA)-tagged MagA was stably expressed in undifferentiated 
embryonic mouse teratocarcinoma, multipotent P19 stem cells to provide a suitable model 
for tracking these cells during differentiation. Western blot and immunocytochemistry 
confirmed the expression and membrane localization of MagA-HA in P19 cells. Elemental 
iron analysis using inductively-coupled plasma mass spectrometry revealed significant iron 
uptake in both parental and MagA-HA-expressing P19 cells, cultured in the presence of iron-
supplemented medium. Withdrawal of this extracellular iron supplement revealed unexpected 
iron export activity in P19 cells, which MagA-HA expression attenuated. The influence of 
iron supplementation on parental and MagA-HA-expressing cells was not reflected by 
longitudinal relaxation rates. Measurement of transverse relaxation rates (R2* and R2) 
reflected changes in total cellular iron content. In particular, the reversible component R2′ 
(R2* ‒ R2) provided a moderately strong correlation to amount of cellular iron, normalized 
to amount of protein. 
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Chapter 1  
1.1 Molecular and Cellular Imaging  
Broadly-speaking, molecular imaging is the in vivo evaluation of biological 
processes at the cellular and molecular level [1]. By using molecular imaging techniques, 
our ability to monitor cells and specific proteins within a living organism has been 
tremendously improved [2]. For example, molecular imaging can be used to locate 
specific groups of cells or the level of a given protein of interest in the cell, permitting 
noninvasive characterization of the progression of disease(s) and development of 
biomarkers of these processes [3]. In addition, the efficiency of treatment in small-animal 
models of human disease can be assessed using molecular imaging [4]. Stem cell therapy, 
for example, is a promising treatment for multiple diseases, such as neurodegenerative 
disease and heart disease; however, in order to understand the fundamental behaviour of 
stem cells, different molecular imaging modalities have been developed to better 
understand stem cell survival, distribution and function in the targeted regions [5]. Many 
traditional imaging modalities such as ultrasound, x-ray computed tomography (CT) and 
magnetic resonance imaging (MRI) are based on nonspecific macroscopic changes that 
distinguish pathological tissues from healthy ones but do not identify changes in gene 
expression and other molecular interactions responsible for the disease [1]. To address 
this shortcoming, molecular imaging attempts to exploit specific probes with intrinsic 
contrast agent properties [2]. This transition from nonspecific to specific labeling 
represents an outstanding improvement in targeting the disease process, providing new 
opportunities for understanding integrative biology and for detecting and characterizing 
disease at earlier stages. 
Molecular imaging has been applied to long-term studies using different imaging      
modalities such as optical imaging, CT, positron emission tomography (PET), single 
photon emission computed tomography (SPECT), ultrasound and MRI. Each of the 
imaging modalities has inherent advantages and limitations. Optical imaging is useful for 
detecting the expression of fluorescent proteins, such as green fluorescent protein (GFP), 
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or the bioluminescent activity of luciferase (e.g. firefly luciferase), which is useful for 
understanding aspects of intracellular activity. GFP, as an example, was identified in 
1962; explored as a reporter gene in 1992 [6]; and then later examined for its ability to 
maintain fluorescence in a variety of organisms [6, 7]. However, the use of GFP for 
monitoring molecular changes in vivo is limited by the depth of light penetration and low 
resolution (2-3 mm for optical fluorescence imaging and 3-5 mm for optical 
bioluminescence) [2]. By comparison, PET and MRI have also been used to monitor gene 
expression in living organisms, with the advantage of satisfactory depth of interrogation.   
Nuclear medicine techniques use small amounts of radioactive material 
(radiopharmaceuticals) to diagnose and treat diseases. PET has been used to evaluate the 
metabolism of a particular organ or tissue by attaching different radioactive atoms, such 
as 18F, 15O or 11C, to substances that are naturally consumed by the target organ or tissue. 
Commonly used substances include 18F-fluorodeoxyglucose [1] and 11C-methionine [8]. 
By using the radiotracers, physiological and biochemical information can be obtained. 
Although spatial resolution is relatively poor with nuclear medicine platforms (namely 
PET and SPECT), co-registration with CT or MRI provides a hybrid imaging solution 
(PET/CT, SPECT/CT, PET/MRI). The short half-life of medical radiotracers is essential 
for the clinical utility of ionizing radiation but constrains direct radiolabelling of cells for 
long periods of time (e.g. Indium-111 has a half-life of 2.8 days) and the number of 
repeat imaging sessions.  
MRI has a number of advantages over other imaging modalities: no ionizing 
radiation is needed; tissue is imaged at high spatial resolution (25-100 µm in preclinical 
settings, and approximately 1 mm in clinical settings); and depth of penetration is not a 
concern [9]. Over the past two decades, MRI has been used in longitudinal studies [10, 
11] for (repetitive) monitoring of stem cell engraftment, tumor growth and metastasis, 
changes in pancreatic beta cell function during diabetes and cardiac cell activity after 
heart attack [12]. Yet, despite all of its strengths, MRI fails to track cellular and 
molecular activities with the sensitivity that has been achieved in optical imaging using 
reporter genes such as the green fluorescent protein and luciferase [1] or in PET using 
radiotracers. Here, the definition of sensitivity is the minimum concentration of imaging 
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agent that can be detected. The sensitivity of MRI is approximately 10-3-10-5 molar, 
which is much lower than the sensitivity of PET (10-11-10-12 molar), optical fluorescence 
imaging (10-9-10-12 molar) and optical bioluminescence imaging (10-15-10-17 molar). In 
order to develop molecular MRI, cells must be labeled with a contrast agent to improve 
cell tracking and the detection of molecular activity [13]. To understand how contrast 
agents can improve MRI, information about how MRI works and why contrast agents 
influence the MR signal will be explained below. 
1.1.1 MRI Relaxometry 
Relaxometry is the study or measurement of nuclear magnetic resonance (NMR) 
relaxation parameters. NMR is a phenomenon that can be observed when a group of 
nuclei containing an odd number of protons and/or neutrons is placed within a strong 
magnetic field. When combined with spatial encoding methods, NMR leads to MRI: a 
tool that can provide images of the macroscopic structure of biological systems. 
Historically the word ‘nuclear’ was dropped from the nomenclature of this imaging 
modality to avoid any misconceptions that there was ionizing radiation involved as in 
Nuclear Medicine. Since more than 60 % of the human body is water (H20), hydrogen is 
the most abundant element imaged in MRI. A hydrogen atom is composed of a nucleus 
(with 1 proton and no neutrons) and a single orbital electron. The hydrogen ion (H+) is 
often referred to as a ‘proton’ since that is the only particle left if the electron is removed. 
Classically, protons are considered spinning charged particles with a small magnetic 
moment typically denoted by the symbol µ. Without an external magnetic field, the 
nuclear moments are in random directions and thus, the vector sum of the nuclear 
magnetic moments (net magnetization, M) will be zero. 
When nuclei with magnetic moments are placed in a strong external magnetic 
field (B0), most magnetic moments will still have a random orientation [14] but there will 
be a small net magnetic moment created (vector sum of all the magnetic moments) 
aligned parallel (low energy state) to B0. Thus, M becomes non-zero and is along the 
direction of the applied magnetic field [15]. 
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 In addition, when protons are placed within B0, they experience a torque caused 
by the interaction between the spins and the magnetic field, and start to precess at an 
angular frequency defined as the Larmor frequency (ω0) and determined by the Larmor 
equation:                            
   ω0 = γ×B0     [1.1]  
In Equation 1.1, γ is the gyromagnetic ratio, which is equal to 42.576 MhzT-1 for 
hydrogen. Thus, the precession frequency is linearly related to the strength of the 
magnetic field. For example, clinical MRI scanners are usually 1.5 Tesla (T) or 3 T and 
provide a precession frequency for hydrogen of approximately 64 MHz and 128 MHz, 
respectively.   
In order to detect the MRI signal, an external oscillating magnetic field (B1) is 
applied perpendicular to B0, i.e. in the x-y plane. The oscillation frequency of B1 is equal 
to ω0. M will rotate (or precess) about B1 with a frequency (ω1) equal to γB1. Since B1 is 
oscillating at the Larmor frequency, effectively it is rotating at the same frequency as the 
‘spins’. The net magnetization rotates away from the Z-axis towards the X-Y plane. The 
angle of rotation (α) of M is dependent on the duration and amplitude of B1. A 90-degree 
pulse occurs when B1 is on long enough to cause a π/2 rotation of M. This transient B1 
magnetic field is known as a radio frequency (RF) pulse since ω1 is in the MHz range. 
Once the RF pulse is turned off, the magnetic moments will continue to precess at the 
Larmor frequency and M will return exponentially to its original value parallel with B0, 
which is defined as the equilibrium state. The process of returning to the equilibrium state 
is referred to as ‘longitudinal’ relaxation. During relaxation, the nuclei lose energy by 
exchange of energy with lattice around the nuclei. The time it takes M to return to 63% of 
its original value following a 90-degree pulse is called T1. In NMR, this is often referred 
to as the spin-lattice relaxation time as the spins give up the ‘extra’ energy they receive to 
the surroundings or ‘lattice’. The lattice produces transient magnetic fields (usually due 
to molecular motion) at the Larmor frequency [15]. 
Following the termination of the B1 RF pulse, the magnetization in the X-Y plane 
(Mxy) will exponentially decay to 0 (excluding the T1 relaxation) and the characteristic 
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time (for Mxy to irreversibly decay to 37% of its original magnitude) for this decay is 
called the transverse relaxation time (T2). This assumes that the only mechanism is 
random fluctuations in the local magnetic field. In reality what is normally observed in 
the free induction decay (FID) is the total effective transverse decay (T2*), which is a 
combination of microscopic de-phasing (T2) and local magnetic field inhomogeneities 
(T2′). T1, T2 and T2* are converted to decay rates (R1 = 1/T1, R2 =1/T2 and R2* = 
1/T2*). The reversible component, R2′, is the difference between R2* and the irreversible 
component, R2 (R2ʹ′ = R2* − R2). Related equations are thoroughly described in section 
2.2.5.4. 
1.1.2 Contrast Agents for Cell Tracking with MRI Relaxometry 
Contrast agents can significantly improve the quality of a biomedical image and 
enable targeted or functional imaging. MRI contrast agents are roughly categorized into 
two groups: exogenous, such as gadolinium (Gd) [16], magnesium (Mg) [17] and super-
paramagnetic iron oxide (SPIO) particles [18] and endogenous agents, such as tyrosinase 
[19], β-galactosidase (β-gal), ferritin and MagA. Most exogenous MRI contrast agents do 
not directly contribute to the signal but alter the signal of the surrounding water protons 
through their effects on relaxation rates.  
Exogenous contrast agents can be roughly divided into two types: those that have 
an influence on R1, such as gadolinium or manganese[20], and those that have an 
influence on R2, such as superparamagnetic iron oxide (SPIO) particles [18]. Iron 
introduces local magnetic field inhomogeneity (i.e., changes in R2ʹ′) and iron oxide-based 
contrast has been increasingly used in MRI either as direct contrast agents in vivo, or as 
indicators for monitoring specific proteins in vitro and in vivo. SPIO nanoparticles are 
commonly used in the research setting and in clinical trials [13], often to label cells for 
tracking with MRI [21]. Cells are usually labeled with SPIO ex vivo and imaged 
following administration. Since the iron oxide nanoparticles are diluted by cell division, 
SPIO-induced contrast may be lost over time. 
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Compared to exogenous contrast agents, endogenous contrast agents can be 
tracked over a long term without dilution caused by cell proliferation. Expression of MRI 
reporter genes, which are under the control of a regulatory promoter, can be either easily 
detectable or capable of storing certain elements that can improve the MRI contrast. 
Genetically engineered cells expressing MRI reporter genes provide information on the 
location, fluctuation and duration of transcriptional activity in living cells and animals. 
Iron-related endogenous contrast agents are produced by the cell’s genetic machinery in 
order to modulate the uptake, storage, and processing of iron [12]. Iron can act as a 
paramagnetic metal depending on its oxidation and structure. In addition, 
iron concentration will have an impact on MRI contrast. A few mammalian iron handling 
proteins have been studies as potential MRI reporters [22]. For example, transferrin 
receptor (TfR) and ferritin, present in mammalian cells, were investigated by researchers 
for the capability of developing T2/T2* contrast on MR images [12, 23-25]. Genes from 
magnetotactic bacteria will be discussed in Section 1.2.  
1.2 Role of MagA Expression in MRI 
1.2.1 Magnetotactic Bacteria 
Magnetotactic bacteria are a group of prokaryotes that can synthesize magnetic 
crystals called “magnetosomes” and typically arrange these in a chain within the cell. 
These bacteria move along an external magnetic field through a process called 
magnetotaxis. Blakemore et al. initially identified this unique phenomenon in the 
microorganisms collected from the salt marshes of Cape Cod in 1975 and called them 
magnetotactic bacteria after discovering the magnetosome structure within the bacteria 
[26].  
Magnetosome crystals are either composed of the magnetite (Fe3O4), or greigite 
(Fe3S4), depending on the species. In comparison to mammalian ferritin, which is a 
ferrihydrite core surrounded by protein, the relaxivity of magnetite or maghemite 
particles in solution is approximately 700 times more than that of ferritin in solution or 
tissue. There are approximately 28 genes involved [27] in the formation of 
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magnetosomes. Although a full understanding of the process of magnetosome formation 
is lacking, many applications of the unique magnetosome compartment have been 
postulated [28], including its utility in cell tracking with MRI [12, 23, 24, 29].   
1.2.2 MagA in Magnetotactic Bacteria 
MagA was one of the genes originally thought to be involved in magnetosome 
formation. Nakamura et al. reported that production of MagA may be involved in the iron 
biomineralization process [30]. When MagA was expressed in E. coli, inverted 
membrane vesicles within cells were shown to transport ferrous iron (Fe(II)) in an 
energy-dependent manner, resulting in Fe(II) accumulation in the vesicle. These 
observations suggested that MagA may function as an H+/Fe(II) antiporter in M. 
magneticum sp. AMB-1 [31]. A full genomic analysis of AMB-1 confirmed that deletions 
in MagA were present among a set of nonmagnetic mutants. Thus, MagA may play a role 
in magnetosome formation, although further study is required to delineate its exact 
function. More recently, a study from Uebe et al. showed that MagA is not an essential 
magnetosome gene [32]. Nevertheless, MagA is a putative iron transport protein and a 
candidate for MRI reporter gene expression [12, 23, 24, 29, 33].  
 
1.2.3 Using MagA for MRI-based Cell Tracking 
MagA and its potential utility in MR cell tracking have been reported and initial 
results indicate that this technique is promising. The first report on MagA-expressing cell 
tracking used human embryonic kidney (HEK) 293 FT cells to express MagA under the 
control of an inducible promoter [29]. Zurkiya et al. introduced MagA from species MS-1 
into a doxycycline-responsive gene construct, and generated a stably expressing cell line 
in 293FT cells. MRI showed that MagA-derived contrast can be formed in vivo in 
response to iron supplementation and can be used to track cells expressing MagA. They 
compared the iron uptake in MagA-expressing cells in three different doxycycline 
induction conditions (0, 0.5, 2 µg/ml) and found that with same amount of iron 
supplementation (200 µM for four days), different amounts of doxycycline changed the 
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iron content of the cells. They also presented electron microscopic and X-ray powder 
diffraction data as evidence of the ability of MagA-expressing 293FT cells to produce 
magnetite nanoparticles.  Goldhawk et al. expressed MagA from species AMB-1 in the 
mouse neuroblastoma N2A cell line and used 11 T micro MRI and a novel dual echo 
sequence (spin echo at an echo time (TE) of 5 ms and gradient echo at TE 15 ms) to 
acquire three-dimensional MRI [33]. An important step in demonstrating the utility of 
MagA-derived MR contrast for cell tracking is to show that MagA expression will lead to 
changes in the relaxation rates, especially the transverse relaxation rates (R2*, R2 and 
R2′). Expression of MagA in N2A cells generates intracellular contrast for MRI detection 
at 11 T as measured by the decay rates [33].  
Sengupta et al. compared the expression of MagA in MDA-MB-435 cells with the 
overexpression of modified ferritin subunits, in which both heavy chain (HF) and light 
chain (LF) lack iron response elements [23]. Their results showed that only transverse 
relaxation rates were significantly higher in iron-supplemented, MagA- and HF+LF-
expressing cells compared to non-supplemented cells and the parental control. R2* 
provided the greatest absolute difference and R2′ showed the greatest relative difference, 
consistent with the notion that R2′ may be a more specific indicator of iron-based contrast 
than R2, as observed in brain tissue. Upon iron supplementation, the ratio of iron and zinc 
increased about 20-fold in both MagA- and HF+LF-expressing cells, while the amount of 
transferrin receptor expressed in these cells decreased more than 6-fold [23]. Thus, 
despite a decrease in iron import, MagA activity resulted in an increase in cellular iron 
content, comparable to unregulated ferritin storage. These results highlight the potential 
of magnetotactic bacterial gene expression for improving MR contrast. 
Understanding the MRI relaxation mechanism in these expression systems is 
important for developing magnetosome-associated genes as cell tracking tools. To 
optimize cell detection and specificity, develop quantification methods, and refine gene-
based iron contrast, a study by Lee et al. investigated the properties of mammalian cells 
over-expressing MagA using 9.4 T NMR [34]. In this study, the relationship between R2 
and interecho time was examined in both parental MDA-MB-435 and MagA-expressing 
cells cultured in the presence and absence of iron supplementation. The relationship 
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between R2 and interecho time was analyzed using the Carr-Purcell-Meiboom-Gill spin 
echo sequence [35] and a model based on water diffusion in weak magnetic field 
inhomogeneities [36] as well as a fast-exchange model [37]. Iron levels were assessed 
with inductively coupled plasma mass spectrometry (ICP-MS). As expected from a 
previous work [23], iron levels in iron-supplemented, MagA-expressing cells were higher 
than in the other cell conditions. With regard to NMR, increases in R2 with increasing 
interecho time were larger in iron-supplemented cells compared to unsupplemented cells 
and the parental control. These findings provide insight into the high field relaxation 
mechanisms in these MagA-expressing cells, which should be valuable for optimizing 
MRI contrast for long-term cell tracking and monitoring of cellular activities. 
 
1.3 Overview of This Thesis 
1.3.1 Hypothesis 
In this thesis, we hypothesized that MagA-induced iron accumulation can 
generate detectable in vivo contrast, measurable by MRI relaxometry, in the P19 model of 
stem cell behaviour. 
1.3.2 Motivation 
This thesis is motivated by the potential of stem cell therapy. Numerous animal 
studies have shown success in delivering stem cells to treat a variety of diseases. Clinical 
studies in stem cell therapy are promising. For example, recent studies show some 
success in cell transplantation in the infarcted heart [38, 39]. 
MRI is widely used in cell tracking. Specifically, cells labeled with magnetically 
visible contrast agents, which are either exogenous or endogenous, have great potential to 
fulfill this goal.  Using exogenous contrast agents, however, there is a limitation in 
localizing those labeled cells over the long term once delivered to the organ. In order to 
study or develop effective cell therapy, researchers have focused on genetically 
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modifying cells to take up iron. Compared to other techniques like labelling the cells with 
exogenous contrast agents (SPIOs), MagA overexpression can provide stable labelling 
for long-term in vitro and in vivo study. 
1.3.3 Choice of Cell Line 
The cell line used in all the experiments of this thesis is a mouse embryonic 
teratocarcinoma denoted P19. These cells possess multipotent stem cell characteristics 
and can differentiate into the three germ layers:  endoderm, mesoderm, and ectoderm, as 
specified by different chemical treatments [40, 41].  
P19 cells grow rapidly without feeder cells and are effectively transfected with 
DNA encoding recombinant genes. Addition of appropriate antibiotics to the cell culture 
readily permits isolation of P19 cells stably expressing a gene of interest.  
1.3.4 Thesis Objectives 
The path for testing the hypothesis includes multiple sequential objectives. The 
first objective (1) is to ensure that the MagA gene from magnetotactic bacteria can be 
inserted into P19 cells and that MagA-transfected P19 cells are able to stably express 
MagA. This was achieved with a hemagglutinin (HA)-tagged MagA expression construct. 
To detect MagA protein, we performed Western blot analysis using a commercial HA 
antibody as well as immunocytochemical localization.  
The second objective (2) aims to demonstrate the level of iron uptake in 
undifferentiated P19 cells and in the presence and absence of MagA-HA expression. Iron 
supplementation was provided to both types of cells. To measure the total iron content in 
parental and MagA-HA-expressing cells, ICP-MS analysis was used. We expected that 
MagA-HA-expressing P19 cells would incorporate more iron than parental cells as 
reported for other cell types [12, 23, 29, 33].  
The third objective (3) is to determine whether undifferentiated, iron-
supplemented parental and MagA-HA-expressing P19 cells can be distinguished using 
MRI relaxometry. For both parental and MagA-HA-expressing P19 cells, transverse 
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relaxation rates (R2*, R2 and R2′) were measured and compared to total cellular iron 
content.  
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Chapter 2  
2.1.  Introduction 
Molecular Imaging has been used in the characterization and measurement of 
biological processes [1] by exploiting molecular probes as contrast agents for imaging 
modalities like CT, MRI and PET [2]. For longitudinal cell tracking by MRI, a few 
techniques for tracking magnetically labeled cells have been proposed, including gene-
based approaches [3]. Previous studies suggest that MagA, a putative iron-transport 
protein found in magnetotactic bacteria, can be used as an endogenous contrast agent for 
MRI [4]. These reports indicate that MagA is involved in increasing cellular iron content, 
as confirmed by MR relaxation rates and elemental analysis [5-7]. 
In the present study, we provide the first report of MagA expression in the P19 
mouse teratocarcinoma cell line. We used an HA tag to verify MagA protein expression 
and localization. We examined the response of parental and MagA-HA-expressing cells 
to culture in the presence and absence of an extracellular iron supplement, measuring 
total cellular iron content by ICP-MS. In addition, we adapted the methods previously 
developed by Sengupta et al. to measure the relaxation rates of parental P19 cells and 
those expressing MagA-HA using 3T MRI [6]. 
2.2. Methods 
2.2.1 Generation of a MagA-HA Expression Construct 
The tagged MagA-HA gene construct was kindly provided by Becky McGirr as a 
cloned insert within pcDNA3.1 Zeo(+), under the control of the cytomegalovirus (CMV) 
constitutive promoter (Life Technologies, Burlington, Canada). Using customized 
primers to incorporate the HA sequence (underlined in reverse MagA_HA 5ʹ′ in Table 1) 
and a published protocol (Goldhawk et al., 2009), MagA was cloned by polymerase chain 
reaction (PCR) from Magnetospirillum magneticum sp. AMB-1 (ATCC, Burlington, 
Canada). The resultant MagA-HA PCR fragment was sub-cloned into pCR2.1-TOPO 
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(Life Technologies, Burlington, Canada) and shuttled into pcDNA 3.1 Zeo(+) at Kpn I/ 
Bam H1 (Figure 2.1).  
 The pcDNA3.1 Zeo(+)/MagA-HA construct expresses the HA epitope tag fused 
to the C-terminus of MagA. The expression of MagA-HA was confirmed by Western blot 
and immunocytochemistry (ICC), using commercially available antibodies (anti-HA 
antibody, anti-p115 antibody). A stable MagA-HA-expressing cell line was obtained 
using Zeocin antibiotic selection, as conferred by the BleoR resistance gene (Figure 2.1) 
and detailed below. 
2.2.2 P19 Cell Culture, Transfection and Iron-loading  
2.2.2.1 Cell of Choice 
Mouse multipotent teratocarcinoma cells (P19, ATCC) were transfected with 
pcDNA3.1 Zeo(+)/MagA-HA and cultured under selection to obtain a clonal cell line 
stably-expressing MagA-HA. Cells were cultured in alpha-minimum essential medium 
(αMEM, Life Technologies, Burlington, Canada) and 10% fetal bovine serum (FBS) and 
maintained under standard cell culture conditions (37oC, 5% CO2), passaging 1:10 when 
the cells achieved 80-90% confluence. Whether replating or harvesting, cells were 
routinely dissociated using 0.25% Trypsin/0.91 mM EDTA (Life Technologies, 
Burlington, Canada). 
2.2.2.2 Transfection Information 
Transfection was performed using Lipofectamine 2000 (Life Technologies, 
Burlington, Canada) according to the manufacturer’s instructions. Cells were 70-80% 
confluent on the day before transfection and replated approximately 24 hours after 
transfection at 1:20. Selection began 24 hours post-transfection using 200 µg Zeocin/ml 
medium. After approximately two weeks under selection, distinct colonies of P19 cells 
appeared on the plate.  Several of these colonies were randomly selected and individually 
replated in 6–well plates for further amplification on 100 mm2 dishes. At confluence, 
these clonal lines were placed in cryostorage and used to examine the expression of 
MagA-HA via Western blot, as described in the next section. 
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2.2.2.3 Iron Loading 
To examine Mag-HA activity, cells were cultured in the presence or absence of 
iron-supplemented medium, containing 250 µM ferric nitrate (Sigma-Aldrich, Oakville, 
Canada). Following 7 days of iron supplementation, select plates were washed twice with 
PBS (phosphate buffered saline, 137mM NaCl/ 2.7 mM KCl/ 10mM HPO42-) and 
returned to non-supplemented medium for an additional 24 hours of culture. At harvest, 
all plates of cells were washed twice with PBS and either prepared for MRI (described in 
Section 2.2.5), or collected for protein analysis. The latter were collected in 1 to 2 ml of 
ice-cold 50 mM Tris/5 mM EDTA pH 8/150 µL Complete Mini protease inhibitor cocktail 
(Roche Diagnostic	  Systems, Laval, Canada) and lysed by sonication. 
Table 1 Sequences of the primers used in the generation of a MagA-HA construct  
 
 
 
 
Primer Name Sequence (5ʹ′-3ʹ′) 
Forward 
MagA_5ʹ′ 
GGTACCGCCACCATGGAACTGCATCATCCCGAACTGACCTAT
GCCGCCATCG 
Reverse 
MagA-HA_3ʹ′ 
CCGAGACCTTAACTTAAGATAGGCATACTACACGGCCTAAT
ACGCATTCCTAGGCGIX 
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Figure 2.1 Diagram of the plasmid vector used for transfection. The plasmid vector 
map of pcDNA3.1 Zeo(+) was modified to indicate the site of insertion of the MagA-HA 
DNA sequence, the relevant promoters, restriction enzyme sites used in cloning, and 
available antibiotic resistance genes allowing selection of clones that stably express the 
inserted DNA. 
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2.2.3 Protein Expression 
2.2.3.1 Western Blot 
Different clonal lines of MagA-HA-expressing P19 cells were cultured in 6-well 
plates until the cells reached confluence. Clonal lines of MagA-HA-expressing P19 cells 
(cell lines isolated as described above in Section 2.1.2) were prepared from cells cultured 
in T75 flasks. At harvest, they were washed twice with PBS	  and collected in 1 mL 50 mM 
Tris/5 mM EDTA pH 8/150 µL Complete Mini protease inhibitor cocktail (Roche 
Diagnostic Systems, Laval, Canada). Cells were lysed by sonication and protein 
concentration was quantified using the BCA Protein Assay Kit [8]  (Thermo Fisher 
Scientific, Mississauga, Canada). Cellular proteins from each sample were separated by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE, 40 µg/lane) on a 
precast 4-12% gradient gel (Life Technologies, Burlington, Canada) and transferred to a 
nitrocellulose membrane using the Original iBlot® Gel Transfer Device (Life 
Technologies, Burlington, Canada). Blots were blocked with 5% blotto/Tris buffered 
saline (TBS), 50 mM Tris-HCl pH 7.6/0.9% NaCl)/0.1% Tween 20 (TBS-T) for one 
hour, followed by overnight incubation at 4oC with a monoclonal antibody against HA 
(mouse anti-HA, 1:1,000 dilution, in 1% blotto/TBS-T). The following day, membranes 
were washed four times in TBS-T and incubated with secondary antibody conjugated to 
horseradish peroxidase (HRP) (HRP-goat anti-mouse Ig (Sigma-Aldrich, Oakville, 
Canada), 1:5,000 dilution, in 1% Blotto/TBS for 1 hour. Immunoblots were subsequently 
washed 3 times with TBS-T and once with TBS prior to development with a 
chemiluminescent substrate (Super Signal, Thermo Scientific). Chemiluminescence was 
captured using GeneSnap7.12 Software (Cambridge, England) while exposed in the 
Chemigenius Gel Doc (Syngene) for 5 min.  
2.2.3.2 Immunocytochemistry (ICC) 
Sterile glass coverslips were placed in 6-well plates and rinsed with PBS prior to 
seeding approximately 1 million MagA-HA-expressing P19 cells per well. At 70-80% 
confluence, cells were washed with PBS, fixed with 2% paraformaldehyde (PFA)/PBS 
for 30 min and permeabilized with 0.25% Triton X-100 (TX-100)/PBS for five min. 
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After washing three more times with PBS, cells were incubated with blocking buffer 
(10% goat serum/1% bovine serum albumin (BSA)/PBS) for one hour. Cells were 
subsequently incubated overnight at 4oC with goat anti-HA (Abcam, 1:100 dilution in 
10% goat serum/1% bovine serum albumin (BSA)/PBS). An antibody against mouse 
Golgi-associated protein p115 (1:50, Transduction Laboratories, Lexington, KY) and 
Alexa Fluor 594-conjugated wheat germ agglutinin (WGA, 5ug/ml in 10% goat 
serum/1% bovine serum albumin (BSA)/PBS, Life Technologies, Burlington, Canada) 
were also used to visualize the Golgi Apparatus and plasma membrane, respectively. The 
secondary antibodies used were: Alexa Fluor 488-conjugated donkey anti-goat 
immunoglobulin (Ig) and Alexa Fluor 594-conjugated donkey anti-mouse Ig (Life 
Technologies, Burlington, Canada) respectively. After incubation with secondary 
antibodies for two to four hours, cover slips were mounted on glass slides using ProLong 
Gold Antifade Reagent (Life Technologies, Burlington, Canada). Cells were then 
visualized with an Olympus IX81 wide field fluorescence microscope. Image acquisition 
was carried out using In Vivo software. Ten optical sections per cell were collected in 
0.2µm steps covering the z-axis field, using a 60 × oil immersion objective lens. Cell 
images were processed using a three-dimensional (3D) blind deconvolution algorithm 
provided in Image-Pro Plus software (Media Cybernetics, Inc., Rockville, MD, USA). 
2.2.4 Trace Element (Iron) Analysis 
Samples were sent to the Analytical Services Laboratory of Surface Science 
Western at Western University (London, Canada) for trace element analysis of iron and 
zinc using ICP-MS. To prepare samples, cells were cultured as described above and 
harvested based on the confluency of T175 flasks, a day or two before or after the actual 
day of MRI scanning. Cells were lysed in 1 mL 50 mM Tris-HCl pH 8/5 mM EDTA/150 
µL Complete Mini protease inhibitor cocktail (Roche Diagnostic Systems, Laval, Canada) 
and sonicated. The total protein from lysis of these cultured cells was quantified using the 
bicinchoninic acid assay (BCA assay) [8]. Zinc provided a measure of cellular redox 
status as well as a point of comparison to amount of iron. Iron content was then 
normalized to quantity of total cellular protein as determined by the BCA assay. For each 
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individual sample group, mean and standard error of the mean (SEM) were calculated in 
Excel, version 14.3.8. 
2.2.5 MRI of MagA-HA-expressing Cells 
2.2.5.1 Phantom Preparation 
 Figure 2.2 depicts the spherical MRI cell phantom set-up for the measurement 
of relaxation rates. Approximately 40-50 million cells were placed in each well. These 
wells were custom-made from an NMR compatible material (Ultem, Lawson imaging 
Prototype Lab). The dimensions of each well are:  inner diameter 4 mm and height 10 
mm. Samples were centrifuged at 400 × g and for 5 min to create a compact layer of cells 
within each well. Cell pellets were overlaid with 1% gelatin (porcine type 1, Sigma-
Aldrich, Oakville, Canada)/PBS and embedded in one hemisphere of a 9cm spherical 
phantom filled with 4% gelatin/PBS. A spherical-shaped phantom was used to minimize 
macroscopic magnetic field inhomogeneity which would interfere with accurate R2' 
measurement. Samples consisted of either parental or MagA-expressing cells, cultured 
under different conditions of iron supplementation:  without extra iron supplementation, 
with iron supplementation (250 µM ferric nitrate), and withdrawal of iron 
supplementation after 7 days of continuous iron supplementation. To form the spherical 
gelatin phantom, the empty hemisphere was filled with 4% gelatin/PBS and placed on top 
of the half containing cell samples. Using a layer of parafilm, air was excluded in order to 
avoid susceptibility artifacts at the interface [6]. 
2.2.5.2 Scanner and Pulse Sequences 
The spherical phantom was placed in a 15-channel knee RF coil and scanned on a 
3T mMR Biograph (Siemens AG, Erlangen, Germany) using previously described 
sequences [6]. To acquire T1-weighed images, inversion recovery spin echo sequences 
were used. Imaging parameters were as follows: echo time (TE) 13 ms; repetition time 
(TR) 4000 ms; six inversion times (TI)= 22, 200, 500, 1000, 2000, 3900ms; flip angle= 
90o; total scanning time approximately 39 min. To acquire T2-weighted images, a single 
echo spin echo sequence and the following imaging parameters were employed: TE=13,  
 22 
 
30, 40, 60, 80, 100, 150, 200, 300 ms; TR=2010ms; flip angle= 90o; total scanning time 
approximately 61 min. To acquire T2*-weighted images, a multi echo gradient echo 
sequence was used with: TE=6.12, 14.64, 23.16, 31.68, 40.2, 50, 60, 70, 79.9 ms; TR= 
200ms; flip angle= 60o; total scanning time approximately 25 min. For all MR images, 
the field of view was 120×120 mm. For T1-weighted images, the volume of the voxels 
was 1.5×0.9×0.9 mm3 and matrix size was 128×128. For T2- and T2*-weighted images, 
the voxel size was 1.5×0.6×0.6 mm3 and matrix size was 192×192.  
 
Figure 2.2 Diagram of the MRI cell phantom used for the measurement of 
relaxation rates. Each hemisphere of a plastic 9-cm spherical mold was filled with 4 % 
gelatin/PBS. Four different samples, prepared from parental and MagA-HA-expressing 
cells cultured in the presence (+Fe) and absence of iron supplementation, were inlaid in 
one of the hemispheres and arranged from left to right as follows: P19 (1), P19 + Fe (2), 
MagA-HA (3), MagA-HA + Fe (4). A plastic marker was used to indicate orientation of 
the samples. 
2.2.5.3 Region of Interest (ROI) 
 The slice thickness was 1.5 mm and selected as shown in Figure 2.3. Slices were 
oriented perpendicular to the sample wells to obtain a cross section through the cell layer 
and avoid voxels from the bottom of the well and the top gelatin layer. Specifically, a 
 23 
 
ROI in each well was drawn using viewer code developed in Matlab 7.9.0 (R2010b), 
including as many voxels as possible while excluding those closest to the wall of the well 
(Figure 2.3 B). Overall, approximately 20 voxels were included in each ROI and average 
signal intensity of the ROI for each time point and relaxation rate (R2, R2* and R1) were 
determined with least-squares curve fitting (SigmaPlot 10.0.inc) of the mean ROI signal. 
Note that manual selection of ROI was done by using a graphic user interface based on 
Matlab 7.9.0 (R2010b) [6]. 
 
Figure 2.3 Localizer images of the spherical gelatin phantom. The images were 
acquired by 3T MRI. A. In the sagittal view of the phantom, a yellow box indicates the 
slice selected for image acquisition. B. A cross sectional view of the phantom shows the 
alignment of sample wells. A plastic peg (black) provides orientation. 
2.2.5.4 Calculation of R1, R2, R2* and R2'  
R1 decay curves were obtained using an inversion recovery pulse sequence. R1 
was determined with least-squares curve fitting of the mean ROI signals using Equation 
2.1.  
        S TI = 𝑆! · (1− 2 · e!!"·!" +   𝑒!!"·!") · 𝑒!!"/!!                                                                                       2.1                
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R2* decay curves (average signal intensity over TEs) were obtained from the data 
acquired using multi-echo spin echo sequences. R2 curves were obtained from single 
echo spin echo pulse sequences. Sigmaplot 10.0 (Systat Software, Germany) was used to 
fit R2 and R2* curves with a single exponential decay equation. A two-parameter model 
was tested using the following equations.   S TE = S!e!!"·!"                                                                                         2.2a                     S TE = S!e!!"·!!∗                                                                                        2.2b                
Once R2* and R2 were determined, R2ʹ′ was calculated from the difference between R2* 
and R2 (R2ʹ′=R2*-R2). For each individual sample group, mean and SEM of relaxation 
rates (R1, R2*, R2 and R2′) were calculated in Excel.  
2.2.6 Data Analysis 
2.2.6.1 Sample Groups  
To perform data analysis, samples were assigned to six groups: 1) parental P19 
cells cultured in non-supplemented medium, P; 2) MagA-HA-expressing P19 cells 
cultured in non-supplemented medium, M; 3) iron-supplemented parental cells, P+Fe; 4) 
iron-supplemented, MagA-HA-expressing P19 cells, M+Fe; 5) P+Fe cells cultured for an 
additional 24 hours in non-supplemented medium, P 24h- Fe; and 6) M+Fe cells cultured 
for an additional 24 hours in non-supplemented medium, M 24h-Fe.  
2.2.6.2 Statistical analysis 
Two-way ANOVA was used to assess main effects and interaction between 
variables. All tests were two-tailed and SPSS version 20.0 was the statistical package 
used. Student’s t-tests were used to evaluate significant differences between parental and 
MagA-HA-expressing P19 cells for each condition of iron supplementation. Linear 
regression was tested with R2' as the dependent variable and iron concentration as the 
independent variable. P<0.05 was set as the threshold of statistical significance. 
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2.3. Results 
2.3.1 Generation of a Stably-expressing Cell Line 
Protein lysates of both untransfected parental P19 and MagA-HA-expressing cells 
were collected and analyzed by Western blot. As shown in Figure 2.4A, protein lysates 
from parental cells (lanes 1 and 2) showed no anti-HA immunostaining. In contrast, 
varying degrees of HA-tagged protein are detected as a single band in transfected cells, 
stably expressing MagA-HA (lanes 3-6 in Figure 2.4B). The predicted molecular weight 
(M.W.) of MagA-HA is 46.8 KDa; the apparent M.W. of anti-HA bands is approximately 
35 KDa, which is similar to results obtained in a recent report [9]. When the same blot 
was reprobed with an anti-β-actin antibody, a single band was stained at a M.W. of 
approximately 40 KDa, indicating relatively constant amounts of a common structural 
protein in each lane (Figure 2.4 C and D). The reported size of β-actin is 42 KDa [10, 11]. 
Therefore, immunoblotting confirms the presence of HA-tagged protein (Figure 2.4B), 
indicating the successful expression of MagA-HA in P19 cells. Comparison of panels B 
and D indicates a highly expressing clone in lane 3, which was selected for use in all 
subsequent experiments. 
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Figure 2.4 Western blots of protein extracted from P19 cells. Lanes 1-2 contain 
protein extracted from untransfected parental P19 cells; lanes 3-6 contain protein from 
MagA-HA-expressing cells. Panels A and B were probed with antibody against HA to 
detect MagA-HA expression. Panels C and D were probed with an antibody against beta-
actin, used as a loading control. Approximate M.W. is indicated in the left margin. 
2.3.2 Localization of MagA-HA in P19 Cells 
Using ICC and the antibody against HA, we examined the cellular localization of 
MagA-HA in P19 cells. As shown in Figure 2.5A, MagA-HA is present at the plasma 
membrane and within the intracellular compartment. Counterstaining with fluorescently-
conjugated wheat germ agglutinin provides confirmation of plasma membrane labelling 
(Figure 2.5 B). Merging of panels A and B (Figure 2.5 C) reveals yellow fluorescence at 
the plasma membrane, verifying the co-localization of MagA-HA and WGA at the 
plasma membrane.  To address the intracellular localization of MagA-HA (Figure 2.6), 
cells were immuno-stained with an antibody specific to the cis-Golgi Apparatus (Figure 
2.6 B). Merging of panels A and B (Figure 2.6 C) reveals intracellular yellow 
fluorescence indicating co-localization of MagA-HA with the cis-Golgi Apparatus 
membrane-associated protein p115. 
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Figure 2.5 MagA-HA co-localizes with WGA at the plasma membrane. P19 cells 
stably expressing MagA-HA were sequentially probed with (A) primary goat anti-HA 
and secondary donkey anti-goat antibody conjugated to Alexa Fluor 488 (green 
fluorescence) and (B) Alexa Fluor 594-conjugated WGA (red fluorescence). Merging 
panels A and B provides yellow fluorescence (C) wherever MagA-HA and WGA co-
localize in the plasma membrane. Scale bar = 15 µm.  
 
Figure 2.6 MagA-HA co-localizes with p115 expression in the Golgi Apparatus. 
P19 cells stably expressing MagA-HA were sequentially probed with (A) primary 
goat anti-HA and secondary Alexa Fluor 488 conjugated donkey anti-goat Ig (green 
fluorescence) and (B) primary mouse anti-p115 and secondary Alexa Fluor 594-
conjugated donkey anti-mouse Ig (red fluorescence). Merging panels A and B 
provides yellow fluorescence (C) wherever MagA-HA and p115 are co-localized in 
the Golgi Apparatus. Scale bar = 15 µm. 
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2.3.3 Analysis of Cellular Iron in MagA-HA-expressing P19 Cells  
The total cellular iron content of MagA-HA-expressing cells was examined using 
ICP-MS and compared to the parental control. As shown in Figure 2.7, elemental iron in 
both parental and MagA-HA-expressing cells is significantly increased after culture in 
iron-supplemented medium containing 250 µM ferric nitrate (P vs. P+Fe, p<0.01; M vs. 
M+Fe, p< 0.01). Under iron supplementation for 7 days, parental and MagA-HA-
expressing P19 cells contain approximately 1580 ± 293 and 2100 ± 297 ng Fe/mg 
protein, respectively; whereas, in unsupplemented culture, parental and MagA-HA-
expressing P19 cells contain approximately 48.9 ± 4.7 and 60.9 ± 12.9 ng Fe/mg protein 
respectively. It is noteworthy that MagA-HA expression does not cause any significant 
change in cellular iron content in the absence of an extracellular iron supplement, 
consistent with previous findings in MDA-MB-435 cells [6]. Surprisingly, however, after 
7 days of iron supplementation total cellular iron content was not significantly different 
(p > 0.05) between MagA-HA-expressing P19 cells and the parental control.  
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Figure 2.7 Elemental Analysis of Iron in Parental and MagA-HA-expressing P19 
Cells.  Total cellular iron content was analyzed by ICP-MS and normalized to total 
cellular protein. Cell samples were cultured at least 7 days in the presence (+Fe) and 
absence (-Fe) of iron supplementation (250 µM ferric nitrate). Total cellular iron content 
is significantly higher in both iron-supplemented cell types compared to the 
unsupplemented samples. Error bars are ± SEM (*, p<0.05). P, parental controls; M, 
MagA-HA-expressing cells; P-Fe: N=6; M-Fe: N=6; P+Fe: N=8; M+Fe: N=5.  
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To further delineate the iron handling activities of P19 cells, their ability to retain 
iron after the withdrawal of the extracellular supplement was examined (Figure 2.8). 
Accordingly, after 7 days of iron supplementation, both parental and MagA-HA-
expressing cells were returned to unsupplemented medium for an additional 24 hours of 
culture. In Figure 2.8, a sharp decline in iron level was observed in the parental cell type 
after one hour, which continued to diminish over 24 hours. However, the total cellular 
iron content of MagA-HA-expressing cells decreased less than the parental control and 
was maintained over 24 hours at a higher level than in parental P19 cells.  
 
Figure 2.8 Time Course of Iron Export in P19 Cells. Both parental (P) and 
MagA-HA-expressing (M) P19 cells were cultured in iron-supplemented medium 
containing 250 µM ferric nitrate for 7 days followed by an additional 24 hours of 
culture in non-supplemented medium. Samples were collected for analysis by ICP-
MS at 1, 2 and 24 hours after the removal of iron supplement and labeled as 1h-Fe, 
2h-Fe and 24h-Fe respectively. Error bars are ± SEM (*, p< 0.05). P+Fe: N=8; 
M+Fe: N=5; 1h-Fe (P, M): N=2; 2h-Fe (P, M): N=2, 24h-Fe (P, M): N=5. 
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Together, Figures 2.7 and 2.8 show that untransfected and MagA-HA-expressing 
P19 cells have a similar capacity to incorporate iron from an extracellular supplement but 
different abilities to retain this iron. The parental P19 cell type demonstrates a substantial 
iron export activity (+Fe vs. 24h-Fe, p < 0.01) as do the MagA-HA-expressing P19 cells 
(+Fe vs. 24h-Fe, p<0.05). However, 24 hours after the withdrawal of iron supplement, 
MagA-HA-expressing cells retain approximately 719 ± 52.6 ng Fe/mg protein, which is 
significantly higher than the parental control (332 ± 53.6 ng Fe/mg protein, p < 0.01).  
2.3.4 MRI of MagA-HA-expressing Cells 
MR phantoms containing cell pellets from parental and MagA-HA-expressing 
P19 samples were scanned at 3T. Figure 2.9 shows the mean values of the longitudinal 
relaxation rates in parental and MagA-HA-expressing P19 cells cultured under three 
different conditions: -Fe, no iron supplementation; +Fe, iron supplementation for at least 
one week; 24h-Fe, at least a week of iron supplementation (+Fe) followed by an 
additional 24 hours of culture in non-supplemented medium. No significant differences in 
R1 measurements are observed between samples (p > 0.05).  
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Figure 2.9 Influence of iron supplementation on R1 in MagA-HA-expressing P19 
cells. Longitudinal relaxation rate was determined in parental cells (P, white bars) and 
MagA-HA-expressing cells (M, black bars) cultured in the absence of iron 
supplementation (-Fe), in medium containing 250 µM ferric nitrate for 7 days (+Fe) and 
after withdrawal of iron from +Fe samples for 24h (24h-Fe). 3T MRI was performed as 
previously described [6]. There is no significant difference between P and M within a 
given culture condition (P-Fe vs. M-Fe and P+Fe vs. M+Fe). Error bars are ± SEM (*, 
p<0.05). P-Fe: N=4; M-Fe: N=4; P+Fe: N=6; M+Fe: N=4; P 24h-Fe:N=2; M 24h-Fe: 
N=3. 
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When comparing the decay curves for R2 (Figure 2.10a) and R2* (Figure 2.10b) 
within 80 ms, R2* shows a higher signal decay rate than R2. This is consistent with a 
previous study in MDA-MB-435 [12]. R2* represents the total transverse relaxation rate 
and includes both the reversible component R2' and the irreversible component R2. In 
Figure 2.10, R2* decay shows a stronger difference between MagA-HA-expressing and 
parental cells than R2 alone.  
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Figure 2.10 Signal Decay Curves for Transverse Relaxation. A comparison between 
(a) R2 and (b) R2* relaxation curves for parental and MagA-HA-expressing cell samples, 
cultured in the presence and absence of iron supplementation. In order to compare the R2 
and R2* curves, only time-points before 80ms are shown in the figure. The R2* curves 
show a greater difference between the MagA-HA-expressing and parental cells than the 
R2 decay curves. 
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Previous studies show that total cellular iron content is significantly correlated to 
R2' [49]. In the present study, transverse relaxation rates, R2, R2* and R2ʹ, all were 
notably different in both parental and MagA-HA-expressing P19 cells. For each 
relaxation rate, significant main effects for the iron condition were found using two-way 
ANOVA (Figures 2.11-2.13, p<0.001). The bar charts in Figure 2.11 and 2.12 show the 
mean values of the transverse relaxation rates of parental and MagA-HA-expressing P19 
cells cultured under 3 different conditions: -Fe, +Fe and 24h-Fe. Significant differences 
in R2* are observed in both parental and MagA-HA-expressing P19 cells for 
continuously iron-supplemented and unsupplemented conditions (Figure 2.11, P-Fe vs. 
P+Fe and M-Fe vs. M+Fe, p < 0.05). Similarly, significant differences in R2 are observed 
in both cell types (Figure 2.12, P-Fe vs. P+Fe, p<0.01 and M-Fe vs. M+Fe, p < 0.05). 
 
 
 
 
 36 
 
 
Figure 2.11 Influence of iron supplementation on R2* in MagA-HA-expressing P19 
cells. R2* was determined in parental cells (P, white bars) and MagA-HA-expressing 
cells (M, black bars) cultured in the absence of iron supplementation (-Fe), in medium 
containing 250 µM ferric nitrate for 7 days (+Fe) and after withdrawal of iron from +Fe 
samples for 24h (24h-Fe). There is no significant difference between P and M within a 
given culture condition (P-Fe vs. M-Fe and P+Fe vs. M+Fe). For different conditions of 
iron supplementation, there is a significant difference in both P-Fe vs. P+Fe and M-Fe vs. 
M+Fe. Error bars are ± SEM (*, p<0.05). P-Fe: N=7; M-Fe: N=4; P+Fe: N=8; M+Fe: 
N=4; P 24h-Fe:N=2; M 24h-Fe: N=3. 
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Figure 2.12 Influence of iron supplementation on R2 in MagA-HA-expressing P19 
cells. R2 was determined in parental cells (P, white bars) and MagA-HA-expressing cells 
(M, black bars) cultured in the absence of iron supplementation (-Fe), in medium 
containing 250 µM ferric nitrate for 7 days (+Fe) and after withdrawal of iron from +Fe 
samples for 24h (24h-Fe). There is no significant difference between P and M within a 
given culture condition (P-Fe vs. M-Fe and P+Fe vs. M+Fe). For different conditions of 
iron supplementation, there is a significant difference in both P-Fe vs. P+Fe and M-Fe vs. 
M+Fe. Error bars are ± SEM (*, p<0.05). P-Fe: N=7; M-Fe: N=4; P+Fe: N=8; M+Fe: 
N=4; P 24h-Fe:N=2; M 24h-Fe: N=3. 
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In Figure 2.13, R2' measurements were comparable between parental and MagA-
HA-expressing P19 cells cultured in either the absence (-Fe) or presence (+Fe) of iron 
supplementation (n = 4-7). Only MagA-HA–expressing P19 cells showed significantly 
higher R2ʹ between two iron conditions (M-Fe vs. M+Fe, p< 0.05). After at least 1 week 
of continuous iron supplementation, parental and MagA-HA-expressing P19 cells were 
returned to culture for a further 24 hours in non-supplemented medium (24h-Fe). R2' 
measurements in this sample set show that R2' for MagA-HA-expressing cells (n = 3) is 
higher than parental cells (n = 2). These findings lend further support to the ICP-MS 
results described above, even though more experiments should be done to reach statistical 
significance.  
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Figure 2.13 Influence of iron supplementation on R2ʹ in MagA-HA-expressing P19 
cells. R2ʹ was determined in parental cells (P, white bars) and MagA-HA-expressing cells 
(M, black bars) cultured in the absence of iron supplementation (-Fe), in medium 
containing 250 µM ferric nitrate for 7 days (+Fe) and after withdrawal of iron from +Fe 
samples for 24h (24h-Fe). There is no significant difference between P and M within a 
given culture condition (P-Fe vs. M-Fe and P+Fe vs. M+Fe). For different conditions of 
iron supplementation, there is a significant difference in both P-Fe vs. P+Fe and M-Fe vs. 
M+Fe. Error bars are ± SEM (*, p<0.05). P-Fe: N=7; M-Fe: N=4; P+Fe: N=8; M+Fe: 
N=4; P 24h-Fe:N=2; M 24h-Fe: N=3. 
Figure 2.14 illustrates the correlation between the reversible transverse relaxation 
rate R2ʹ and total cellular iron content. Data from both parental and MagA-HA-
expressing P19 cells, cultured in the presence (+Fe and 24h-Fe) and absence (-Fe) of iron 
supplementation, are graphed. In general, unsupplemented cultures exhibit low R2′, rising 
with a moderately strong correlation to the increase in total cellular iron, normalized to 
amount of protein. The Pearson’s correlation coefficient is approximately 0.6 (r2 = 0.34, n 
= 13, p < 0.05).   
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Figure 2.14 Comparison of R2ʹ′  and total cellular iron content. Samples include 
parental cells (P, circles) and MagA-HA-expressing cells (M, squares) cultured in the 
absence of iron supplementation medium (-Fe, n=2, open symbols), in medium 
containing 250 µM ferric nitrate for 7 days (+Fe, n=2-3, black symbols) and after 
withdrawal of iron for 24h (24h-Fe, n=2, dotted symbols). Relaxation rate measurements 
were obtained from cell samples mounted in a gelatin phantom and scanned at 3T. The 
plot shows a linear regression analysis of the relationship between R2′ and total cellular 
iron content (p < 0.05). 
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2.4. Discussion 
 In this study, we examined the expression and function of MagA-HA in 
undifferentiated P19 cells to extend the development of gene-based iron labelling for 
MRI to a model of stem cell biology. MR relaxation rates were investigated in the context 
of total cellular iron content in both parental and MagA-HA-expressing cells cultured 
under various conditions of iron supplementation (-Fe, +Fe and 24h-Fe). The results 
reveal new features of P19 iron biochemistry and demonstrate the potential for MagA to 
retain iron in P19 cells and alter MR contrast.  
 
Protein analyses 
A MagA expression construct incorporating an HA tag on the C-terminus expands 
the study of MagA expression to include protein analyses using immune techniques and a 
commercial antibody. A Western blot of MagA-HA-expressing P19 cells was used to 
identify a highly expressing clonal cell line (Figure 2.4). The approximate M.W. of 
MagA-HA is 35 KDa in agreement with a recent report using HA-tagged MagA to study 
the MR signal in a mouse embryonic stem cell line [9]. Although the predicted M.W. of 
MagA-HA is approximately 47 KDa, no post-translational processing of the N-terminal 
has been reported to date. 
 
While Western blotting confirmed the expression of MagA-HA in P19 cells, ICC 
was conducted to examine the localization of MagA. In bacteria, MagA is a putative iron 
transport protein localized in the membrane compartment [13]. In mammalian P19 cells, 
HA-tagged protein was immuno-stained on the surface and within the intracellular 
compartment of MagA-HA-expressing cells. Wheat germ agglutinin is an approximately 
36 kDa carbohydrate-binding protein with an affinity for sialic acid and N-
acetylglucosaminyl sugar residues, which are predominately expressed on the plasma 
membrane of mammalian cells [14]. This lectin was used to examine the membrane 
localization of MagA-HA. Immunocytochemical analysis showed that MagA-HA and 
WGA co-localize at the plasma membrane of P19 cells (Figure 2.5). To investigate the 
intracellular localization of MagA-HA, we used an antibody specific for p115, a Golgi 
Apparatus associated protein. The Golgi Apparatus is an organelle in eukaryotic cells 
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responsible for sorting protein and lipid, routing them to the appropriate cellular 
compartment. Newly synthesized protein from the endoplasmic reticulum enters the 
Golgi on the cis side and leaves on the trans side facing the plasma membrane [15]. In the 
Golgi Apparatus, p115 is required for vesicle transport from the cis to the medial 
compartments [16, 17]. Thus, the Golgi Apparatus functions as a molecular assembly line 
in which membrane proteins may undergo extensive post-translational modification en 
route to their final destination in the cell. This includes processing of proteins for 
secretion or membrane localization [15]. Co-localization of MagA-HA and p115 in the 
Golgi Apparatus implies that overexpressed protein is accumulating in the Golgi 
vesicle(s) responsible for organizing membrane-associated protein within the cell (Figure 
2.6). These results are consistent with published [7, 13] and unpublished data indicating 
that MagA-HA is a membrane protein. 
Iron analysis  
Mammalian cells display elaborate regulation of iron uptake, storage, export and 
distribution of intracellular iron [18]. It is a constituent of such important proteins as 
hemoglobin, cytochromes, oxygenases, flavoproteins, and redoxins [19]. For iron uptake, 
transferrin is an important extracellular antioxidant that binds iron tightly under 
physiological conditions so that virtually no free iron is available for the production of 
free radicals. The delivery of iron to cells involves receptor-mediated uptake of 
transferrin-bound iron [20]. Moreover, by controlling the expression of the transferrin 
receptor, through the interaction of iron binding proteins with iron response elements, 
mammalian cells regulate the amount of iron they import from the extracellular 
environment. This form of transferrin receptor-mediated iron uptake is present in most 
cell types [21]. In contrast, Ferroportin 1 (Fpn1) is the only iron exporter identified to 
date [18, 22-24] and its expression is largely restricted to enterocytes, macrophages and 
hepatocytes [25]. Once Fe(II) is exported across the basal membrane of the cell by Fpn1, 
the iron is oxidized by hephaestin, a multi-copper oxidase that interacts with plasma 
transferrin  [26, 27].  
 
Thus, iron and its careful regulation are of crucial importance to living cells. In 
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cultured P19 cells, the total cellular iron content increases dramatically in response to an 
extracellular iron supplement (Figure 2.7). Continuous culture in the presence of iron-
supplemented medium results in a significant 32-fold increase (p < 0.01) in total cellular 
iron content. However, cellular iron content in parental cells also decreased abruptly with 
time when iron supplementation was withdrawn (Figure 2.8). Within two hours, the total 
cellular iron content decreased to 567 ± 181 ng iron/mg protein, approaching baseline 
levels by 24 hours (Figure 2.8, p<0.05).  
 
While MagA-HA-expressing P19 cells exhibited a similar uptake of iron as the 
parental cell type after week long culture in iron-supplemented medium, the decrease in 
total cellular iron content, when extracellular supplementation was withdrawn, was not as 
great. In MagA-HA-expressing cells, total cellular iron content was more than 2-fold 
greater that the parental control even after withdrawal of iron supplement for 24 h (Figure 
2.8; p<0.01). The iron export function of P19 cells is unexpected and reveals previously 
unrecognized iron handling abilities in this cell type. The preliminary data for parental 
P19 cells (white bars for 1h-Fe and 2h-Fe in Figure 2.8) indicates high ferroportin 
activity in addition to high transferrin receptor activity (Figure 2.7). This is similar to 
what is reported for M2 macrophages [28]. The ability of MagA-HA expression to retain 
iron in P19 cells indicates the potential of MagA activity to modulate intrinsic iron export 
function.  
MRI analysis 
While the exact mechanism of MagA function in bacterial and mammalian cells 
has not been fully characterized, the results in P19 agree with previous studies indicating 
that MagA expression increases iron incorporation in mammalian cells. With 
measurement of relaxation rates, we explored the potential for contrast enhancement in 
P19 cells by the expression of MagA-HA. Longitudinal relaxation rates (Figure 2.9) were 
influenced very little, by the striking increase in cellular iron and this is consistent with 
other publications [6, 29]. On the other hand, the transverse relaxation rates (R2* and R2, 
Figures 2.11 and 2.12, respectively) were strongly affected by iron supplementation in 
both parental and MagA-HA-expressing P19 cells.  
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Compared to unsupplemented cells, either parental or MagA-HA-expressing P19 
cells, the transverse relaxation rates (R2* and R2) are significantly higher in iron-
supplemented cells. However, there is no significant difference in these relaxation rates 
between MagA-HA-expressing and parental P19 cells cultured continuously in the 
presence of iron-supplemented medium. This is consistent with ICP-MS results, which 
indicate that total cellular iron content in iron-supplemented MagA-HA-expressing cells 
(M+Fe in Figure 2.13) is no different than the iron supplemented P19 control (P+Fe in 
Figure 2.13). These data are not consistent with previous studies [4, 6, 7, 9]. In other cell 
types, like MDA-MB-435, which downregulate transferrin receptor expression in 
response to iron supplementation, there is little or no increase in cellular iron content or 
relaxation rate in the absence of MagA expression [6]. Results in P19 suggest that the 
parental cell type possesses high iron import activity, which masks the activity of MagA, 
a putative iron transport protein from magnetotactic bacteria. 
The detection of iron export activity in P19 cells prompted an investigation of 
relaxation rates in samples collected 24 hours after the removal of iron supplement. 
While there was little difference in R2 and R2* measurements at this time point, the iron 
specificity of R2ʹ′ measurements indicated the potential for discerning smaller differences 
in cellular iron content (Figure 2.13). R2′ was strongly affected by iron supplementation 
in MagA-HA-expressing P19 cells (p < 0.05) and revealed little change in MR contrast 
24 hours after the withdrawal of extracellular iron. Although the sample size needs to be 
increased for statistical comparisons, it appears that R2′ may be a useful indicator of 
cellular iron content in P19 and perhaps other iron exporting cells, like macrophages. In 
MDA-MB-435 [6], the correlation between R2ʹ′ and total cellular iron content for MagA-
expressing cells is robust (r = 0.96), with a low y-intercept indicating better iron-related 
specificity than R2. In P19 cells, the correlation between R2ʹ′ and total cellular iron 
content for parental and MagA-HA-expressing P19 cells is moderately strong (r = 0.6, 
Figure 2.14). We speculate that the rapid rate of iron export, particularly in the parental 
cell type, may be impacting this result. Using the MRI preparation protocol previously 
published [6], it takes about 2-3 hours to prepare cell samples for the MRI experiment. 
As shown in Figure 2.8, within two hours of the withdrawal of iron supplementation, 
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cellular iron content of parental P19 drops to approximately one third of the value 
measured in continuously supplemented (+Fe) controls. In this time frame, the amount of 
iron also decreased in MagA-HA-expressing P19 cells, by approximately 2-fold. Once 
more time points are examined to fully characterize the iron export activity in parental 
and MagA-HA-expressing P19 cells, the rate of iron export may be used to calibrate the 
flux in cellular iron content and its relationship to MRI measurements. Further 
experiments are warranted. 
2.5. Conclusion 
Western blots and ICC demonstrated the expression and membrane localization of 
MagA-HA in P19 cells. Extracellular iron supplementation of cultured cells significantly 
increased the total iron content in both parental and MagA-HA-expressing P19 cells, 
resulting in an increase in transverse relaxation rates. Withdrawal of iron supplementation 
revealed substantial iron export activity in parental P19 cells. MagA-HA expression 
attenuated this iron export function, permitting the cell to retain iron and MR contrast for 
a longer period of time. This is the first report of the influence of MagA expression on an 
iron exporting cell type. 
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Chapter 3  
3.1 Summary 
This thesis describes the successful expression of MagA, a gene from the 
magnetotactic bacterium species AMB-1, in undifferentiated P19 mouse embryonal 
carcinoma cells and generation of a stable MagA-HA-expressing clonal cell line. Our 
study reports the cellular location of MagA-HA using immunocytochemistry, the 
response of MagA-HA-expressing cells to extracellular iron supplementation using mass 
spectrometry and their magnetic properties using MR relaxation rates. A comparison to 
parental P19 cells reveals (1) pronounced iron uptake and export functions not previously 
described in this model of stem cell behaviour, (2) the influence of MagA on mammalian 
iron export and (3) the ability of MagA-HA expression to provide MR contrast in an iron-
exporting cell type. 
 
3.2 Future Directions 
P19 cells are a mouse teratocarcinoma, multipotent stem cell line, which can be 
chemically induced to differentiate into different cell lineages. Previous studies have 
shown that P19 cells can be differentiated down the mesodermal lineage using dimethyl 
sulfoxide (DMSO) [1]. Using this procedure, successfully differentiated P19 cells display 
a beating cardiac muscle cell phenotype in culture, with appropriate 
immunocytochemical staining of cardiac biomarkers [2]. In preliminary experiments, 
differentiated MagA-HA-expressing P19 cells also exhibited a beating cardiac muscle 
cell phenotype. However, further immunocytochemical experiments need to be done to 
show that the expression of MagA-HA is fully compatible with cardiac differentiation. 
 
Magnetosomes, the membrane bound crystals of magnetite or greigite, permit 
magnetotactic bacteria to navigate along the geomagnetic field. In order to accumulate 
the large quantities of iron needed for magnetosome production, pathways for active iron 
uptake into the cell, and more specifically the magnetosomal compartment, are very 
important. It is still not entirely clear which genes are involved in the process of 
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magnetosome iron transport. Early genetic and biochemical studies indicated that MagA 
might be involved in magnetosomal iron uptake. This led to development of MagA as a 
genetic MRI reporter for non-invasive cell tracking in vivo. However, the gene for MagA 
is not located within the magnetosome genomic island [3], which is assumed to contain 
the essential genes necessary for the formation of magnetosomes in bacteria [4]. MmsF, 
for example, is one of the genes encoded in the MAI region. Previous study indicates that 
MmsF plays an important role in biomineralization of mature magnetite crystals, which 
might make it suitable for study if MmsF-expressing P19 cells can increase cellular 
relaxation rates.  
 
During the time course of iron export in P19 cells (Figure 2.8), we saw a high iron 
export activity in both parental and MagA-HA-expressing cells. More experiments 
detailing the time course of iron export after withdrawal of iron supplementation are 
needed in order to fully understand the influence of iron export. Zurkiya et al. showed 
that iron uptake in 2B5 cells changes with time and doxycycline induction of MagA 
expression [5]. An appreciation of the pattern of iron export in P19 cells may shed some 
light on the variability between total cellular iron content and R2′. Preparation of the MR 
phantom required large scale cell culture and in the time it took to harvest the samples 
more iron may have been exported from the cells, potentially affecting the correlation of 
cellular iron content and MR relaxation rates.   
 
As shown in the appendix B, uncertainties in relaxation rate measurements are 
well within an acceptable range, and do not explain the variability in MRI measurements. 
However, as shown in Figure 2.8, iron content changes dramatically within hours of 
withdrawal of iron supplementation, which suggests that iron content may vary during 
the hours needed to prepare the MRI samples. As discussed above, iron homeostasis is a 
tightly regulated process. The only recognized iron export protein in mammalian cells is 
Fpn1, which is mainly found in enterocytes, macrophages and hepatocytes. Hepcidin is 
an important regulator of iron homeostasis:  degrading the iron exporter Fpn 1 and thus 
influencing the exporting ability of cells. This has been substantiated by studies showing 
that increased hepcidin concentrations in plasma can cause anemia. On the other hand, 
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deficiency of hepcidin can cause iron overload [6]. In P19 cells, the addition of hepcidin 
to culture medium prior to cell harvest might improve the relationship between total iron 
content and R2′ by interrupting any residual iron export occurring during the hours of cell 
phantom preparation.   
 
In MDA-MB-435 cells [7], there is a strong correlation between the reversible 
transverse relaxation rate, R2′ and total cellular iron content (r = 0.96). However, there is 
not as strong a correlation between R2ʹ′ and total cellular iron content in P19 cells (Figure 
2.14); the Pearson’s correlation coefficient, 0.6 (r2 = 0.34, n = 13), implies a moderate 
correlation and suggests that while 34% of the variance in R2ʹ′ is explained by a change in 
total cellular iron content, other factors are important. In addition to rate of iron export, 
discussed above, further analysis, for example using an independent t test on both 
parental and MagA-HA-expressing samples collected at 24h - Fe, will require additional 
experiments.  
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Appendix A: MagA-HA sequence 
Figure A. MagA-HA sequence in pcDNA3.1 Zeo(+)/MagA-HA. The sequence is 
from the 5' insertion site to the stop codon following the HA tag. The numbers indicate 
the location of the sequence in the plasmid. The HA tag is in bold, and MagA is 
underlined. The start and stop codons are shaded. Unique restriction sites within this 
region of the plasmid are identified. 
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Appendix B: Raw data of relaxation rates for parental and 
MagA-HA expressing P19 cells in different media condition 
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Uncertainties correspond to each data point. ✖:, Uncertainty information was lost due to 
computer malfunction. AVE: average; SD: standard deviation; SEM: standard error of the 
mean. 
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